Genome-wide DNA methylation analysis for type 2 diabetes mellitus and cardiovascular disease: from a 23-Year follow-up in the Da Qing Diabetes Prevention Study

26 August 2017 (00:00 - 00:00)

Organised by:

6 More presentations in this session

Presentation thumbnail

Use of insulin providers versus insulin sensitizers and risk of out-of-hospital cardiac arrest - a nationwide case-time-control study

Mr G. Hognason Mohr (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial

Doctor T. Aung (Oxford, GB)

Abstract Slides

Presentation thumbnail

Detailed description of myocardial infarctions and the various subtypes in the LEADER trial

Professor M. Nauck (Bochum, DE)

Abstract Slides

Presentation thumbnail

Diabetes risk assessment of cardiovascular free individuals, through the calculation and evaluation of a lifestyle index; results of the 10-year follow up of the ATTICA study.

Professor D. Panagiotakos (Athens, GR)

Abstract Slides

Presentation thumbnail

Association of subclinical atherosclerosis with telomere length and glycemic variability

Doctor E. Dudinskaya (Moscow, RU)

Access the full session

Session thumbnail

Diabetes mellitus: from "omics to complications"

The Event

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources